LUCAS WONG to Lung Neoplasms
This is a "connection" page, showing publications LUCAS WONG has written about Lung Neoplasms.
Connection Strength
0.071
-
Phase II study of olaratumab with paclitaxel/carboplatin (P/C) or P/C alone in previously untreated advanced NSCLC. Lung Cancer. 2017 09; 111:108-115.
Score: 0.071